|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
98,530,000 |
Market
Cap: |
18.88(M) |
Last
Volume: |
78,874 |
Avg
Vol: |
78,656 |
52
Week Range: |
$0.1916 - $0.1916 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
31,758 |
51,758 |
77,758 |
93,627 |
Total Buy Value |
$102,237 |
$190,037 |
$294,295 |
$352,590 |
Total People Bought |
4 |
4 |
4 |
4 |
Total Buy Transactions |
4 |
5 |
8 |
11 |
Total Shares Sold |
0 |
7,084 |
41,479 |
98,636 |
Total Sell Value |
$0 |
$36,199 |
$179,159 |
$193,613 |
Total People Sold |
0 |
1 |
5 |
5 |
Total Sell Transactions |
0 |
1 |
8 |
13 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rouhandeh Steven H |
Director |
|
2021-01-15 |
4 |
AS |
$2.02 |
$164,086 |
I/I |
(81,283) |
11,806,409 |
|
-14% |
|
Rouhandeh Steven H |
Director |
|
2021-01-14 |
4 |
AS |
$2.00 |
$63,213 |
I/I |
(31,600) |
11,887,692 |
|
-17% |
|
Wider Todd |
Director |
|
2021-01-04 |
4 |
AS |
$1.54 |
$52,064 |
D/D |
(33,876) |
276,625 |
|
-24% |
|
Mann Paul Elliot |
Director |
|
2021-01-04 |
4 |
AS |
$1.54 |
$46,891 |
D/D |
(30,488) |
132,664 |
|
-24% |
|
Wider Todd |
Director |
|
2020-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(609,755) |
310,501 |
|
- |
|
Mann Paul Elliot |
Director |
|
2020-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(609,755) |
163,152 |
|
- |
|
Mann Paul Elliot |
Director |
|
2020-12-18 |
4 |
AS |
$1.59 |
$27,099 |
D/D |
(17,079) |
772,907 |
|
15% |
|
Mann Paul Elliot |
Director |
|
2020-12-02 |
4 |
AS |
$1.49 |
$45,369 |
D/D |
(30,488) |
789,986 |
|
3% |
|
Wider Todd |
Director |
|
2020-12-02 |
4 |
AS |
$1.49 |
$50,546 |
D/D |
(33,876) |
920,256 |
|
3% |
|
Wider Todd |
Director |
|
2020-11-23 |
4 |
AS |
$1.33 |
$23,981 |
D/D |
(17,969) |
954,132 |
|
23% |
|
Wider Todd |
Director |
|
2020-11-02 |
4 |
AS |
$1.04 |
$35,106 |
D/D |
(33,876) |
972,101 |
|
124% |
|
Mann Paul Elliot |
Director |
|
2020-11-02 |
4 |
AS |
$1.04 |
$31,589 |
D/D |
(30,488) |
820,474 |
|
124% |
|
Amoroso Michael |
COOOfficer |
|
2020-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
245,455 |
|
67% |
|
Carr Edward |
Chief Accounting Officer |
|
2020-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
143,182 |
196,736 |
|
- |
|
Mann Paul Elliot |
Director |
|
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
813,008 |
850,962 |
|
- |
|
Wider Todd |
Director |
|
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
813,008 |
1,005,977 |
|
- |
|
Rouhandeh Steven H |
Director |
|
2020-09-15 |
4 |
AS |
$2.00 |
$3,981 |
I/I |
(1,989) |
11,919,292 |
|
1% |
|
Rouhandeh Steven H |
Director |
|
2020-09-11 |
4 |
AS |
$2.01 |
$9,244 |
I/I |
(4,600) |
11,921,281 |
|
21% |
|
Rouhandeh Steven H |
Director |
|
2020-09-10 |
4 |
AS |
$2.08 |
$152,482 |
I/I |
(73,411) |
11,925,881 |
|
4% |
|
Rouhandeh Steven H |
Director |
|
2020-08-17 |
4 |
AS |
$2.85 |
$228,312 |
I/I |
(80,000) |
11,999,292 |
|
-47% |
|
Mann Paul Elliot |
Director |
|
2020-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
37,954 |
37,954 |
|
- |
|
Migausky George V |
Director |
|
2020-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
37,954 |
37,954 |
|
- |
|
Buono Stefano |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,969 |
287,969 |
|
- |
|
Rouhandeh Steven H |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
495,000 |
|
- |
|
Silverstein Christine Berni |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,000 |
|
- |
|
156 Records found
|
|
Page 5 of 7 |
|
|